Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.58 USD | -0.75% | -4.15% | -6.00% |
17/05 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
02/04 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.00% | 18.53M | |
+37.78% | 723B | |
+31.69% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.06% | 244B | |
-4.42% | 208B | |
+10.18% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- Kala Pharmaceuticals : JPMorgan Downgrades Kala Pharmaceuticals to Neutral From Overweight